In mouse models of highfat dietinduced liver steatosis, it significantly inhibits hepatic NNMT activity, reduces NAM methylation, increases NAD+ and SAM levels, enhances mitochondrial fatty acid oxidation, reduces hepatic triglyceride and lipid accumulation, lowers lipotoxicity markers (e.g., malondialdehyde, transaminases), improves hepatocellular injury, and reverses steatosis
What BPC-157 does: BPC-157 is commonly discussed for tendon, ligament, soft tissue, gut, joint, and inflammation-related recovery
B cells in autoimmune and neurodegenerative central nervous system diseases
Pricing depends on the protocol, formulation, and dosage determined during your consultation
Meta-analysis Meta-analysis was performed using the R statistical program, R version 4.4.2 (The R Foundation for Statistical Computing, Wirtschaftsuniversitt Wien, Vienna, Austria) (Sterne et al., 2016